Biovotion in Goldman Sachs Report
A preview to the future of digital health devices
An extremely sleek all-in-one medical grade monitor, a preview to what the future of digital health devices will look like. Given the breadth of Biovotion’s device capabilities, the company could theoretically attack the entirety of our $200b chronic disease management savings opportunities. The technology is among the best we have seen and Biovotion appears to be a prime candidate for industry partnerships. The company can generate substantial revenues as a medical/consumer wearable. The space represents a multi-billion-dollar opportunity.